The briefing examines how the pharmaceuticals and medical equipment industry is performing globally and in the largest countries in terms of pharmaceuticals and medical equipment output. The report also provides data for production, market size, imports, exports, industry costs, industry profitability and number of companies. The industry and market overview provide benchmarks against other countries in the region.
This report comes in PPT.
The global pharmaceuticals and medical equipment industry is projected to maintain steady growth to 2029 driven by strong consumer demand in key regions. However, despite the positive outlook, the industry will need to navigate ongoing supply chain issues, economic uncertainties and rising input costs, which remain potential threats to sustained growth and profit margins.
China maintains its global lead, accounting for 25% of global pharmaceuticals and medical equipment production value. The rapid expansion of China's healthcare sector and increased investments in research and development are forecast to support future growth and help China gain greater access to global supply chains.
Private consumers and governments, especially in developed economies, are increasingly scrutinising pricing of pharmaceuticals and look for value-based pricing and reimbursement models. This will push medical companies to reduce prices of most popular drugs and search for new sales models to maintain profit margins intact.
Changing global trade structure challenges established research, production and regulatory networks of the pharmaceuticals industry. Although in most cases pharma products are exempt from higher tariffs, growing uncertainty will encourage companies to invest more into production localisation where possible and implement supply diversification strategies.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!